Pranoprofen

DB13514InvestigationalSmall molecule

Pranoprofen is a topical anti-inflammatory agent used for the treatment of non-infectious inflammatory conditions such as blepharitis and conjunctivitis. Pranoprofen ophthalmic solution may also be used post-operatively to manage inflammation. A medication used in eye drops to manage eye swelling and discomfort caused by a variety of eye conditions.

Mechanism: Pranoprofen is a cyclo-oxygenase inhibitor.
Curator reviewed · 1 reference
Formula / weight: C₁₅H₁₃NO₃ · 255.2686 g/mol (avg)

Resolves to

Compound

UNII2R7O1ET613CAS52549-17-4ChEMBLCHEMBL367463ChEBI32040

Clinical / RWD

ATCS01BC09

Structure

InChIKeyTVQZAMVBTVNYLA-UHFFFAOYSA-NSMILESCC(C(O)=O)C1=CC2=C(OC3=C(C2)C=CC=N3)C=C1

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

163Drug interactionsStructured to mechanism, not free text

5Clinical trialsPhase, status and sponsor resolved per trial

2Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

3Marketed productsAcross 2 countries and 3 labellers

1ATC codeIncluding every combination product, plus 20 drug categories

4+ReferencesStructured and connected to the statements they support

Which other approved drugs treat the same conditions as Pranoprofen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account